SparingVision’s lead asset SPVN06 clears IND application in the US for the treatment of retinitis pigmentosa
SparingVision’s lead asset SPVN06 clears IND application in the US for the treatment of retinitis…
SparingVision’s lead asset SPVN06 clears IND application in the US for the treatment of retinitis…
SparingVision’s lead asset SPVN06 clears IND application in the US for the treatment of retinitis…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
MOUNTAIN VIEW, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a…
MOUNTAIN VIEW, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a…
NEW HAVEN, Conn., Dec. 01, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
NEW HAVEN, Conn., Dec. 01, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
Company to Share Clinical Data from KT-474 Phase I Patient Cohort and Oncology Pipeline WATERTOWN,…
Company to Share Clinical Data from KT-474 Phase I Patient Cohort and Oncology Pipeline WATERTOWN,…
Ukrainian surgeon collaborators will present at the VI Congress of Vascular Surgeons, Phlebologists, and Angiologists…
Ukrainian surgeon collaborators will present at the VI Congress of Vascular Surgeons, Phlebologists, and Angiologists…
Highlighting consistent preclinical and clinical data demonstrating the potential of HGF/MET as a neuroprotective and…
Highlighting consistent preclinical and clinical data demonstrating the potential of HGF/MET as a neuroprotective and…
TNX-801 is Based on the Sequence of a Natural Isolate of Horsepox and is Believed…
TNX-801 is Based on the Sequence of a Natural Isolate of Horsepox and is Believed…
PITTSBURGH, Dec. 01, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a…
PITTSBURGH, Dec. 01, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a…
KOL headshot KOL headshot KOL headshot KOL headshot KOL headshot KOL headshot — Featured speakers…
KOL headshot KOL headshot KOL headshot KOL headshot KOL headshot KOL headshot — Featured speakers…